About Healx

Healx combines artificial intelligence with pharmacological expertise to accelerate treatments for rare diseases. Traditional drug development has a 5% success rate, leaving 90% of rare diseases without therapies. By analysing drug and disease data, Healx identifies connections between existing compounds and rare conditions, enabling faster, cost effective pathways to new treatments. The company operates multiple programmes in parallel, advancing therapies from prediction to patient. Its approach de-risks discovery by repurposing known compounds. This patient inspired model brings hope to 300 million people living with rare diseases, partnering with patient groups, pharmaceutical companies and research institutions.